Tag: in-vitro lung model market.

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The In-Vitro Lung Model Market Expected To Grow In Terms Of Size?

The market size of the in-vitro lung model has increased at a rapid pace in the past few years. Its value is projected to expand from $0.44 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of 21.0%. The impressive growth during the historic time frame can be traced back to a rise in the incidences of respiratory ailments, augmented emphasis on individualized treatment strategies, an increasing curiosity in repurposing drugs, focusing on precise medical approaches, and an escalating cognizance of environmental health hazards.

The market size for in-vitro lung models is projected to experience significant growth in the coming years, swelling to “$1.11 billion by 2029” with a compound annual growth rate (CAGR) of 19.8%. This expected surge in the future can be credited to several factors such as the necessity for drug development, the rise in preclinical trials, heightened awareness about respiratory toxicology, emphasis on regenerative medicine, escalating environmental concerns, and an upward trend in the geriatric population. The forecast period sees key trends like a growing demand for drug testing, improvements in 3D printing technology, progress in organ-on-chip technology, the application of AI and machine learning, incorporation of sensors and monitoring equipment, broadening of applications out of the pharmaceutical sphere, and the creation of disease-specific models.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

What Core Drivers Are Expected To Influence The In-Vitro Lung Model Market?

The expansion of the in vitro lung model market is projected to be propelled by the rising number of clinical trials. The surge in clinical studies owes to the escalating demand for sophisticated medical interventions, increased healthcare requirements, and the search for innovative remedies to challenging health matters. Clinical studies are research endeavors that evaluate the efficacy of fresh medical methods in humans. In vitro lung models contribute to these trials by offering a regulated environment for studying the impacts of compounds on lung tissue, facilitating drug screening, toxicity evaluation, disease simulation and deciphering disease processes. For example, as of January 2024, data from ClinicalTrials.gov, a clinical trial registry based in the US, showed an uptick in registered clinical trials worldwide, rising to 477,230 by the end of 2023 from 437,508 in 2022. Consequently, the escalation in clinical trials spurs the growth of the in vitro lung model market.

Which Segments Define The Structure Of The In-Vitro Lung Model Market?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Strategic Shifts And Innovations Are Influencing The In-Vitro Lung Model Market?

Major firms in the invitro lung model market are innovating by creating three-dimensional (3D) respiratory tissue models to increase physiological relevance and intricacy within their models. These models are produced by cultivating specific respiratory cells within a unique environment, which effectively enables them to form a 3D structure that replicates the function and form of the respiratory system, serving as a more representative platform for drug research and testing. A prime example of this is MatTek Corporation, a biotechnology company based in the US, which launched an inventive 3D respiratory tissue model, EpiNasal in April 2023. Developed from primary human nasal epithelial cells, EpiNasal imitates the three-dimensional structure and functionality of the nasal epithelium, comprising mucus-producing goblet cells, functional tight junctions, and rhythmically beating cilia. EpiNasal’s launch marked an addition to MatTek’s suite of 3D respiratory tissue models, providing a comprehensive platforms for examining the impact of drugs, chemicals, pathogens, and consumer products on the human respiratory system.

Which Firms Are Making The Biggest Impact In The In-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Region Is Forecasted To Lead The In-Vitro Lung Model Market In The Coming Years?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Current and Projected Market Size of the In-Vitro Lung Model Market Through 2034?#_x000D_

The market for in-vitro lung models has witnessed significant expansion lately. The market scale is expected to surge from $0.44 billion in 2024 to $0.54 billion in 2025, marking a compound annual growth rate (CAGR) of 21.0%. The historical growth can be linked to increase in respiratory illness cases, heightened attention towards personalized healthcare, rising curiosity in drug reorientation, accentuation on precision medicine techniques, and growing consciousness about environmental health hazards._x000D_

_x000D_

The market for in-vitro lung models is projected to expand substantially in the coming years, reaching a valuation of $1.11 billion in 2029 with a compound annual growth rate (CAGR) of 19.8%. The anticipated growth within this period can be accredited to various factors such as the needs of drug development, the increase in preclinical testing, the heightened awareness of respiratory toxicology, a focus on regenerative medicine, escalating environmental concerns, and a rise in the elderly population. Key trends within this forecast period encompass heightened demand for drug testing, advancements in 3D printing technology, organ-on-chip technology development, integration of artificial intelligence (AI) and machine learning, sensor and monitoring devices integration, usage expansion beyond pharmaceuticals, and creation of disease-specific models._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the In-Vitro Lung Model Market?#_x000D_

The escalating number of clinical studies is anticipated to stimulate the expansion of the in vitro lung model market in the future. Clinical trials, which explore the effectiveness of new medical strategies in humans, are on the rise due to the surge in advanced medical treatment requirements, growing healthcare demands, and the quest for original solutions to intricate health problems. In vitro lung models contribute to clinical trials by offering a regulated setting to scrutinize the impacts of substances on lung tissue, assisting in medication testing, toxicity evaluation, disease modeling, and comprehension of disease mechanisms. For example, in January 2024, ClinicalTrials.gov, a US-based clinical trial registry, reported that by the end of 2023, there were globally 477,230 clinical trials registered on ClinicalTrials.gov, which was an increase from the 437,508 registered clinical trials in 2022. Consequently, the growth in clinical studies fuels the in vitro lung model market._x000D_

_x000D_

#Which Key Market Segments Comprise the In-Vitro Lung Model Market and Drive Its Revenue Growth?#_x000D_

The in-vitro lung model market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model_x000D_

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications_x000D_

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures_x000D_

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the In-Vitro Lung Model Market Expansion Across the Globe?#_x000D_

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#What Are the Key Market Trends in theIn-Vitro Lung Model Market Over the Coming Years?#_x000D_

Key players in the invitro lung model market are shifting towards the development of 3D respiratory tissue models, enhancing both the physiological significance and intricacy of their models. These advanced 3D respiratory tissue models, which are formed by culturing certain respiratory cells in a distinct environment, allow the cells to build a three-dimensional structure. This replicated structure closely imitates the function and morphology of the respiratory system and serves as a more relevant platform for research and drug testing. An example is the introduction of EpiNasal by MatTek Corporation, an American biotech company, in April 2023. EpiNasal is a cutting-edge 3D respiratory tissue model consisting of primary human nasal epithelial cells, aiming to mimic the 3D structure and the functionality of the nasal epithelium. This includes mucus-generating goblet cells, operational tight junctions, and cilia that pulsate. The launch of EpiNasal broadens MatTek’s range of 3D respiratory tissue models, providing a holistic method for analysing the impact of pharmaceuticals, chemicals, pathogens, and consumer goods on the human respiratory system._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report_x000D_

_x000D_

#How Is the In-Vitro Lung Model Market Conceptually Defined?#_x000D_

An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the In-Vitro Lung Model Market From 2025 To 2029?

In recent times, there has been an exponential growth in the market size of the in-vitro lung model, going from $0.44 billion in 2024 to $0.54 billion in 2025. This represents a compound annual growth rate (CAGR) of 21.3%. The growth recorded in the historical period is linked to the rising occurrence of respiratory diseases, increased attention to personalized healthcare, the growing interest in reusing drugs, focus on precision medicine strategies, and an increased understanding of environmental health risks.

What Is the Projected Market Size of the In-Vitro Lung Model Market?

Over the next few years, a significant expansion of the in-vitro lung model market is projected. By 2029, the value of this market is predicted to reach $1.16 billion, representing a compound annual growth rate (CAGR) of 21.0%. The anticipated market growth within this period is likely driven by factors such as the demand for drug development, a surge in preclinical testing, increased understanding of respiratory toxicology, focus on regenerative medicine, escalating environmental concerns, and a rising geriatric population. Noteworthy tendencies for this period encompass a heightened call for drug testing, the progression of 3D printing and organ-on-chip technologies, the incorporation of artificial intelligence and machine learning, the integration of sensor and monitoring tools, application diversification beyond pharmaceuticals, and the creation of disease-specific models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Who are the Major Competitors in the In-Vitro Lung Model Market Outlook?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

What Is Fueling Growth in the In-Vitro Lung Model Market?

The in vitro lung model market’s growth is anticipated to be spurred by the rise in clinical investigations. These refer to research studies examining the efficacy of novel medical methods in human subjects. The surge in these studies is fuelled by the escalating demand for sophisticated medical therapies, heightened health care requirements, and the search for innovative answers to intricate health issues. In vitro lung models contribute to clinical trials by offering a regulated setting for examining the impact of substances on lung tissue, facilitating drug trials, toxicity evaluations, disease modeling, and comprehending disease processes. For instance, according to ClinicalTrials.gov, a US-based clinical trial register, by the end of 2023, the total number of registered clinical trials worldwide was 477,230, an increase from the 437,508 trials registered in 2022. Consequently, the surge in clinical investigations is stimulating the in vitro lung model market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which In-Vitro Lung Model Market Segments Are Growing the Fastest?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Industry Trends Are Shaping the Future of the In-Vitro Lung Model Market?

Leading firms in the invitro lung model market are moving towards the construction of 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. The formation of these models involves cultivating particular respiratory cells in a specific environment, which enables them to form a structure that resembles the actual function and shape of the respiratory system. This makes for a more suitable platform for research and drug trials. For example, MatTek Corporation, a biotech company based in the US, launched EpiNasal, a novel 3D respiratory tissue model composed of primary human nasal epithelial cells, in April 2023. It successfully emulates the 3D structure and function of the nasal epithelium, inclusive of goblet cells that produce mucus, functional tight junctions, and cilia with a beating motion. The addition of EpiNasal marks an extension in MatTek’s range of 3D respiratory tissue models. This model serves as a thorough system to analyze the impact of drugs, chemicals, disease-causing agents, and consumer goods on the human respiratory system.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Countries Are Leading the In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

This Report Delivers Insight On:

1. How big is the in-vitro lung model market, and how is it changing globally?

2. Who are the major companies in the in-vitro lung model market, and how are they performing?

3. What are the key opportunities and risks in the in-vitro lung model market right now?

4. Which products or customer segments are growing the most in the in-vitro lung model market?

5. What factors are helping or slowing down the growth of the in-vitro lung model market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the In-Vitro Lung Model Market From 2025 To 2029?

In recent times, there has been an exponential growth in the market size of the in-vitro lung model, going from $0.44 billion in 2024 to $0.54 billion in 2025. This represents a compound annual growth rate (CAGR) of 21.3%. The growth recorded in the historical period is linked to the rising occurrence of respiratory diseases, increased attention to personalized healthcare, the growing interest in reusing drugs, focus on precision medicine strategies, and an increased understanding of environmental health risks.

What Is the Projected Market Size of the In-Vitro Lung Model Market?

Over the next few years, a significant expansion of the in-vitro lung model market is projected. By 2029, the value of this market is predicted to reach $1.16 billion, representing a compound annual growth rate (CAGR) of 21.0%. The anticipated market growth within this period is likely driven by factors such as the demand for drug development, a surge in preclinical testing, increased understanding of respiratory toxicology, focus on regenerative medicine, escalating environmental concerns, and a rising geriatric population. Noteworthy tendencies for this period encompass a heightened call for drug testing, the progression of 3D printing and organ-on-chip technologies, the incorporation of artificial intelligence and machine learning, the integration of sensor and monitoring tools, application diversification beyond pharmaceuticals, and the creation of disease-specific models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Who are the Major Competitors in the In-Vitro Lung Model Market Outlook?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

What Is Fueling Growth in the In-Vitro Lung Model Market?

The in vitro lung model market’s growth is anticipated to be spurred by the rise in clinical investigations. These refer to research studies examining the efficacy of novel medical methods in human subjects. The surge in these studies is fuelled by the escalating demand for sophisticated medical therapies, heightened health care requirements, and the search for innovative answers to intricate health issues. In vitro lung models contribute to clinical trials by offering a regulated setting for examining the impact of substances on lung tissue, facilitating drug trials, toxicity evaluations, disease modeling, and comprehending disease processes. For instance, according to ClinicalTrials.gov, a US-based clinical trial register, by the end of 2023, the total number of registered clinical trials worldwide was 477,230, an increase from the 437,508 trials registered in 2022. Consequently, the surge in clinical investigations is stimulating the in vitro lung model market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which In-Vitro Lung Model Market Segments Are Growing the Fastest?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Which Industry Trends Are Shaping the Future of the In-Vitro Lung Model Market?

Leading firms in the invitro lung model market are moving towards the construction of 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. The formation of these models involves cultivating particular respiratory cells in a specific environment, which enables them to form a structure that resembles the actual function and shape of the respiratory system. This makes for a more suitable platform for research and drug trials. For example, MatTek Corporation, a biotech company based in the US, launched EpiNasal, a novel 3D respiratory tissue model composed of primary human nasal epithelial cells, in April 2023. It successfully emulates the 3D structure and function of the nasal epithelium, inclusive of goblet cells that produce mucus, functional tight junctions, and cilia with a beating motion. The addition of EpiNasal marks an extension in MatTek’s range of 3D respiratory tissue models. This model serves as a thorough system to analyze the impact of drugs, chemicals, disease-causing agents, and consumer goods on the human respiratory system.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Countries Are Leading the In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

This Report Delivers Insight On:

1. How big is the in-vitro lung model market, and how is it changing globally?

2. Who are the major companies in the in-vitro lung model market, and how are they performing?

3. What are the key opportunities and risks in the in-vitro lung model market right now?

4. Which products or customer segments are growing the most in the in-vitro lung model market?

5. What factors are helping or slowing down the growth of the in-vitro lung model market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the in-vitro lung model industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the In-Vitro Lung Model Market’s Growth Trajectory From 2025 To 2034?

Over the last few years, the market size of the in-vitro lung model has witnessed a rapid expansion. It is projected to increase from $0.44 billion in 2024 to $0.54 billion in 2025, at a compound annual growth rate (CAGR) of 21.3%. This significant growth during the historic period can be attributed to several factors, such as the rise in respiratory diseases, amplified attention on personalized medicine, increased interest in reusing drugs, focus on precision medicine methods, and a heightened awareness regarding environmental health risks.

In the coming years, the market size of the in-vitro lung model is expected to witness a skyrocketing growth, reaching $1.16 billion in 2029 with a compound annual growth rate (CAGR) of 21.0%. This projected growth during the forecast period is propelled by various factors such as the need for drug development, an increase in preclinical testing, heightened awareness about respiratory toxicology, a focus on regenerative medicine, escalating environmental worries, and a growing elderly population. The forecast period is also set to see dominant trends including a high demand for drug testing, breakthroughs in 3D printing technology and organ-on-chip technology, the fusion of AI and machine learning, the incorporation of sensors and tracking devices, widening applications outside pharmaceuticals, and the development of disease-specific models.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Which Primay Drivers Are Accelerating Growth in the In-Vitro Lung Model Market?

The surge in clinical research is predicted to boost the expansion of the in vitro lung model market. Clinical studies, which evaluate new medical methodologies’ effectiveness in humans, are on the rise. This increase is fueled by the burgeoning demand for sophisticated medical treatments, escalating healthcare necessities, and the quest for groundbreaking solutions to intricate health concerns. In vitro lung models contribute to clinical trials by offering a regulated environment to examine the impact of substances on lung tissue, assisting in drug testing, toxicity evaluation, disease simulation, and comprehending disease processes. For instance, as per ClinicalTrials.gov, a US-run clinical trial registry, there were 477,230 clinical trials registered globally on ClinicalTrials.gov by the close of 2023. This signifies a rise when compared to 437,508 registered clinical trials in 2022. Consequently, the surge in clinical research is fueling the in vitro lung model market.

How Is the In-Vitro Lung Model Market Segmented?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which Regions Are Key Players in the Growth of the In-Vitro Lung Model Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Key Trends Are Shaping the Future of the In-Vitro Lung Model Market?

Key players in the invitro lung model market are now focusing on creating 3D respiratory tissue models to increase the physiological relevance and intricacy of their models. This is done by growing particular respiratory cells in a unique environment that enables them to form into a structure mimicking the functionality and morphology of the respiratory system, hence presenting a platform that is more relevant physiologically for research and drug testing purposes. For example, MatTek Corporation, a biotechnology company from the US, launched EpiNasal in April 2023, which is a novel 3D respiratory tissue model constructed from primary human nasal epithelial cells. This model successfully simulates the three-dimensional structure and operation of the nasal epithelium, inclusive of functional tight junctions, mucus-producing goblet cells, and beating cilia. The introduction of EpiNasal has expanded MatTek’s array of 3D respiratory tissue models, offering a comprehensive system to analyze the impact of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

How Is the In-Vitro Lung Model Market Defined and What Are Its Core Parameters?

An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Are the Primary Drivers Supporting the Market Growth of theIn-Vitro Lung Model Market?

The escalating number of clinical trials is projected to stimulate the expansion of the in vitro lung model market. Clinical trials are research studies evaluating the effectiveness of new medical strategies in humans. The rise in clinical trials is fuelled by the escalating demand for sophisticated medical treatments, growing healthcare requirements, and the search for innovative answers to intricate health challenges. In vitro lung models play a crucial role in clinical trials by offering a regulated setting to investigate the impact of substances on lung tissues. This aids in drug testing, toxicity evaluation, disease modeling, and gaining insights into disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, at the end of 2023, the number of registered clinical trials worldwide stood at 477,230, marking an increase from 437,508 registered trials in 2022. Therefore, the rise in clinical research stimulates the expansion of the in vitro lung model market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

#How Will the CAGR of the In-Vitro Lung Model Market Influence Its Overall Growth by 2034?

In recent years, the in-vitro lung model market has seen a significant upswing. The market size, which is estimated at $0.44 billion in 2024, is projected to increase to $0.54 billion in 2025, registering a compound annual growth rate (CAGR) of 21.3%. Factors like the rising incidence of respiratory illnesses, the heightened attention toward personalized medicine, burgeoning interest in drug repurposing, a focus on precision medication strategies, as well as increased cognizance of environmental health dangers have collectively abetted the growth during the historic period.

The market for in-vitro lung models is projected to see immense expansion in the coming few years, reaching a valuation of $1.16 billion in 2029 with a CAGR of 21.0%. This projected surge during the forecast duration can be credited to factors such as the need for drug development, the escalation in preclinical trials, rising consciousness about respiratory toxicology, attention on regenerative medicine, intensifying environmental concerns, and an enlarging elderly population. Key trends for the forecast duration encompass escalating demand for drug examination, progress in 3D printing technology, advancements in the technology of organ-on-a-chip, incorporation of AI and machine learning, the blending of sensors and monitoring gadgets, broadening of uses beyond the pharmaceutical sector, and the formulation of disease-specific models.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

What Are the Latest Innovations Influencing theIn-Vitro Lung Model Market?

Top firms in the invitro lung model industry are focusing on the development of 3D respiratory tissue models to improve the physiological relevance and complexity of their models. The 3D respiratory tissue models are developed by culturing chosen respiratory cells in a specified environment, which facilitates their organization into a three-dimensional structure that mimics the morphology and function of the respiratory system. This in turn provides a platform for research and drug testing that is more in line with human physiology. For example, in April 2023, MatTek Corporation, a biotech firm based in the US, launched EpiNasal, a breakthrough 3D respiratory tissue model constructed from primary human nasal epithelial cells. This innovative model reproduces the three-dimensionality and functionality of nasal epithelium, complete with the mucus-synthesizing goblet cells, functional tight junctions, and oscillating cilia. The rollout of EpiNasal has extended MatTek’s suite of 3D respiratory tissue models. This model presents a comprehensive setup for analyzing the impact of pharmaceuticals, chemicals, pathogens, and consumer goods on the human respiratory system.

Who Are the Major Industry Players Accelerating Growth in theIn-Vitro Lung Model Market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which Primary Segments of the In-Vitro Lung Model Market Are Driving Growth and Industry Transformations?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of theIn-Vitro Lung Model Market?# Market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2025, By The Business Research Company:

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/healthcare-specialty-enzymes-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the in-vitro lung model market grown in recent years?

The market for the in-vitro lung model has seen a significant expansion in recent times. It is projected to increase from $0.44 billion in 2024 to $0.54 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 21.3%. Factors such as the increasing instances of respiratory diseases, heightened emphasis on individualized medicine, renewed interest in drug repurposing, focus on precision medicine methodologies, and heightened awareness about environmental health hazards have contributed to the growth during the historic period.

How is the in-vitro lung model market size expected to evolve during the forecast period?

The market for in-vitro lung models is slated for substantial expansion in the coming years, potentially reaching a considerable size of $1.16 billion by 2029, with a compound annual growth rate of 21.0%. This anticipated increase during the projection period can be credited to various factors such as the necessity for drug development, the escalation in preclinical testing, a heightened understanding of respiratory toxicology, a shift towards regenerative medicine, escalating environmental concerns, and a rise in the elderly population. The forecast period is likely to observe significant trends including a surge in demand for drug testing, progression in 3D printing technology, advancements in organ-on-chip technology, application of artificial intelligence and machine learning, inclusion of sensors and monitoring devices, broadening of usage beyond pharmaceuticals, and the creation of disease-specific models.

Get your in-vitro lung model market report here!

https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report

Which key drivers are propelling the in-vitro lung model market’s growth?

The growth of the in vitro lung model market is predicted to be driven by the rise in clinical research. These research studies, which ascertain the efficacy of new medical treatments in humans, are spurred by the growing demand for superior healthcare treatments, elevated healthcare requirements, and the quest for creative remedies to intricate health problems. In vitro lung models facilitate these clinical trials by presenting a regulated setting to examine the impact of compounds on lung tissue. This assists in endeavors such as drug testing, toxicity evaluations, disease modeling, and comprehending disease pathways. For example, data from ClinicalTrials.gov, a clinical trial registry based in the U.S, reveals that by the end of 2023, the number of registered clinical trials worldwide on their site stood at 477,230. This marks an upsurge from the 437,508 trials registered in 2022. Consequently, the escalation in clinical research propels the in vitro lung model market.

What are the market segments in the in-vitro lung model industry?

The in-vitro lung model market covered in this report is segmented –

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model

2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications

3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures

2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp

Which leading companies are shaping the growth of the in-vitro lung model market?

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

Which trends are expected to transform the in-vitro lung model market?

Leading firms working in the in-vitro lung model industry are advancing their prototypes with the help of 3D respiratory tissue models to increase their physiological relevance and complexity. Through a specialized environment, certain respiratory cells are cultured to form 3D structures that closely resemble the function and structure of the respiratory system providing a more accurate platform for drug testing and research. For example, MatTek Corporation, a biotechnology firm based in the US, launched a unique 3D respiratory tissue model known as EpiNasal, using primary human nasal epithelial cells in April 2023. EpiNasal mimics the three-dimensional structure and functionality of the nasal epithelium, including mucus-producing goblet cells, working tight junctions, and beating cilia. The launch of EpiNasal broadens MatTek’s line of 3D respiratory tissue models. This sophisticated model is an encompassing system for analyzing the impact of consumer products, pharmaceuticals, pathogens, and chemicals on the human respiratory system.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15837

Which geographic areas are influencing the growth of the in-vitro lung model market?

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

Enzymes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031

https://www.thebusinessresearchcompany.com/report/healthcare-specialty-enzymes-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: